BiotechTubeBiotechTube
Home/Pipeline/JNJ-6372

JNJ-6372

Lung Cancer

Phase 2Active

Key Facts

Indication
Lung Cancer
Phase
Phase 2
Status
Active
Company
Johnson & Johnson

About Johnson & Johnson

Founded in 1886, Johnson & Johnson operates as a multinational healthcare corporation headquartered in New Brunswick, New Jersey. The company's pharmaceutical division, Janssen, is a global leader in oncology, immunology, and neuroscience with blockbuster drugs like Stelara, Darzalex, and Remicade. J&J combines deep scientific expertise with extensive global reach, serving patients in over 175 countries while maintaining one of the industry's strongest R&D pipelines.

View full company profile

Therapeutic Areas

OncologyImmunologyNeuroscienceInfectious DiseasesCardiovascularMetabolism

Other Lung Cancer Drugs

DrugCompanyPhase
Alpha DaRTAlpha Tau MedicalNot Specified
SelinexorKaryopharm TherapeuticsClinical Trials
Lung Cancer VaccineAnixa BiosciencesDiscovery
15dPMJ2Claradele PharmaceuticalsResearch
SUPLEXAAlloplex BiotherapeuticsPhase 1